findmyKOL
Clinical trialNCT04977453RecruitingPhase 1/PHASE2Interventional

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

SponsorGI Innovation, Inc.Enrollment317Advanced Solid TumorCervical CancerClear Cell Renal Cell Cancer (ccRCC)Metastatic Solid TumorSquamous Cell Non Small Cell Lung CancerUrothelial Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • the Catholic University of Korea Seoul St.Mary'S Hospital

    Seoul, Banpo-daero, South Korea

    In Ho Kim
    Recruiting
  • Seoul National University Bundang Hospital

    Seoul, Bundang-gu, South Korea

    EunHee Jung
    Recruiting
  • Chungnam National University Hospital

    Daejeon, Daejeon, South Korea

    HyoJin Lee, M.D., Ph.D.
    Recruiting
  • Samsung Medical Center

    Seoul, Gangnam, South Korea

    Se Hoon Park
    Recruiting
  • the Catholic University of Korea St. Vincent'S Hospital

    Suwon, Kyeonggi-do, South Korea

    Byoung-Yong Shim, M.D., Ph.D.
    Recruiting
  • Korea University Anam Hospital

    Seoul, Seongbuk-gu, South Korea

    SooHyeon Lee, M.D.
    Recruiting
  • Ewha Womans University Mokdong Hospital

    Seoul, Yangcheon-gu, South Korea

    Jeong Min Cho
    Recruiting
  • Asan Medical Center

    Seoul, South Korea

    Jae Lyun Lee, M.D., Ph.D.
    Recruiting
  • Yonsei University Health System, Severance Hospital

    Seoul, South Korea

    Byoung Chul Cho, M.D., Ph.D.Sang Joon Shin, M.D., Ph.D.
    Recruiting
  • Yonsei University Health System, Severance Hospital

    Seoul, South Korea

    Jung-Yun Lee, M.D., Ph.D.
    Recruiting
United States
  • Tisch Cancer Institute (tci), Icahn School of Medicine

    New York, New York, United States

    Thomas Marron, MD, PhD
    Recruiting
  • Carolina Biooncology Institute

    Huntersville, North Carolina, United States

    John Powderly, M.D., Ph.D.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Aug 2021
Primary completion
30 Jun 2028
Completion
30 Jun 2028
Last update posted
15 May 2026
Registered enrollment
317
Registry id
NCT04977453
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.